Kyle Knight赞助的临床试验
总计761个结果
-
Molecular Insight Pharmaceuticals, Inc.完全的
-
Molecular Insight Pharmaceuticals, Inc.完全的嗜铬细胞瘤 | 副神经节瘤 | 类癌
-
InfraredxBright Research Partners完全的
-
Molecular Insight Pharmaceuticals, Inc.批准上市
-
Molecular Insight Pharmaceuticals, Inc.完全的
-
Molecular Insight Pharmaceuticals, Inc.完全的
-
Molecular Insight Pharmaceuticals, Inc.完全的
-
Molecular Insight Pharmaceuticals, Inc.终止
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science University尚未招聘
-
OHSU Knight Cancer InstituteOregon Health and Science University; Incyte Corporation招聘中
-
OHSU Knight Cancer InstituteOregon Health and Science University; Incyte Corporation招聘中
-
OHSU Knight Cancer InstituteOregon Health and Science University; Celgene Corporation完全的
-
OHSU Knight Cancer InstituteNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science University完全的
-
OHSU Knight Cancer InstituteNovartis Pharmaceuticals; Oregon Health and Science University完全的肉瘤 | 复发性成人软组织肉瘤 | 成人横纹肌肉瘤 | 成人肺泡软部肉瘤 | 成人血管肉瘤 | 成人促结缔组织增生性小圆细胞瘤 | 成人上皮样血管内皮瘤 | 成人上皮样肉瘤 | 成人骨外粘液样软骨肉瘤 | 成人骨外骨肉瘤 | 成人纤维肉瘤 | 成人平滑肌肉瘤 | 成人脂肪肉瘤 | 成人恶性周围神经鞘瘤 | 成人滑膜肉瘤 | III 期成人软组织肉瘤 AJCC v7 | 恶性成人血管外皮细胞瘤 | IV 期成人软组织肉瘤 AJCC v7 | 成人未分化多形性肉瘤美国
-
OHSU Knight Cancer InstituteOregon Health and Science University; Kuni Foundation招聘中
-
OHSU Knight Cancer InstituteOregon Health and Science University; Celgene Corporation招聘中
-
OHSU Knight Cancer InstituteOregon Health and Science University; Eisai Inc.主动,不招人
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); AMAG Pharmaceuticals, Inc.终止
-
Insight Lifetech Co., Ltd.完全的
-
Church & Dwight Company, Inc.完全的
-
Church & Dwight Company, Inc.完全的
-
Molecular Insight Pharmaceuticals, Inc.完全的
-
Molecular Insight Pharmaceuticals, Inc.完全的
-
Molecular Insight Pharmaceuticals, Inc.完全的
-
Molecular Insight Pharmaceuticals, Inc.完全的
-
Molecular Insight Pharmaceuticals, Inc.撤销
-
Molecular Insight Pharmaceuticals, Inc.终止